Please login to the form below

Not currently logged in
Email:
Password:

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon.

He brings over two decades worth of experience in senior financial management positions to the group, holding roles in technology organisations including SITA, Hewlett-Packard and Electronic Arts.

He said: “Our ground breaking technology and approach are revolutionising the healthcare field, improving the prognosis of patients worldwide and I look forward to supporting the company through its journey of growth and development.”

Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance.

His new role will see him take responsibility for the company’s finance and accounting functions.

Jurgi Camblong, chief executive officer and co-founder of Sophia Genetics, said: “Matillon’s track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”

19th January 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Stick or Twist? Healthcare brands in a (post) COVID-19 world
...
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic
...
Lockdown entertainment or healthcare revolution? The role of video games in healthcare
...